<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">25539873</PMID>        <DateCompleted>            <Year>2015</Year>            <Month>02</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2014</Year>            <Month>12</Month>            <Day>25</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1872-7123</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>220 Suppl 1</Volume>                    <PubDate>                        <Year>2014</Year>                        <Month>Dec</Month>                    </PubDate>                </JournalIssue>                <Title>Psychiatry research</Title>                <ISOAbbreviation>Psychiatry Res</ISOAbbreviation>            </Journal>            <ArticleTitle>Understanding the role of adjunctive nonpharmacological therapies in management of the multiple pathways to depression.</ArticleTitle>            <Pagination>                <MedlinePgn>S34-44</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0165-1781(14)70004-6</ELocationID>            <ELocationID EIdType="pii" ValidYN="Y">S0165-1781(14)70004-6</ELocationID>            <Abstract>                <AbstractText>Major depressive disorder (MDD) is a common disorder with a lifetime prevalence of 16.2% and the fourth highest cause of disability globally. It is hypothesized to be a syndromatic manifestation of multiple pathological processes leading to similar clinical manifestation. MDD is associated with at least three categories of peripheral hormone-type factors including neurotrophic factors, proinflammatory cytokines, and processes that impair regulation of the hypothalamic-pituitary-adrenocortical axis. Neuroimaging studies have identified functional abnormalities including subcortical systems associated with reward and emotion processing, medial prefrontal and anterior cingulate cortical regions and the lateral prefrontal cortical systems involved in cognitive control and voluntary emotion regulation. Studies investigating the effects of psychotherapy and pharmacotherapy on functional brain measures show normalization of brain function with return to euthymia. Nevertheless, approximately 50% of patients with MDD will not respond sufficiently and 60 to 70% will not achieve full remission with first-line pharmacotherapy, therefore clinicians strive to improve patient responses through the use of adjunct therapies. This review discusses recent research in the various biological processes associated with MDD as well as recent data in support of the use of adjunctive non-pharmacological therapies including psychotherapy, bibliotherapy, Internet therapy, &quot;natural&quot; or herbal approaches, exercise therapy, and somatic therapies. </AbstractText>                <CopyrightInformation>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Velehorschi</LastName>                    <ForeName>Corina</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Toldo Neurobehavioral Institute, Windsor Regional Hospital, Windsor, ON, Canada; Schulich School of Medicine, Western University, London, ON, Canada. Electronic address: corina_velehorschi@wrh.on.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bleau</LastName>                    <ForeName>Pierre</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Faculty of Medicine, McGill University; McGill University Health Centre, McGill University, Montreal, QC, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vermani</LastName>                    <ForeName>Monica</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>START Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada; Department of Psychology, Lakehead University, Thunder Bay, ON, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Furtado</LastName>                    <ForeName>Melissa</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>START Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Klassen</LastName>                    <ForeName>Larry J</ForeName>                    <Initials>LJ</Initials>                    <AffiliationInfo>                        <Affiliation>Eden Mental Health Centre, Winkler, MB, Canada.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Ireland</Country>            <MedlineTA>Psychiatry Res</MedlineTA>            <NlmUniqueID>7911385</NlmUniqueID>            <ISSNLinking>0165-1781</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName>                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Adjunct therapy</Keyword>            <Keyword MajorTopicYN="N">Major depressive disorder</Keyword>            <Keyword MajorTopicYN="N">Metabolic syndrome</Keyword>            <Keyword MajorTopicYN="N">Psychotherapy</Keyword>            <Keyword MajorTopicYN="N">Somatic therapies</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2013</Year>                <Month>10</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2014</Year>                <Month>10</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2014</Year>                <Month>12</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2014</Year>                <Month>12</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2015</Year>                <Month>2</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">25539873</ArticleId>            <ArticleId IdType="pii">S0165-1781(14)70004-6</ArticleId>            <ArticleId IdType="doi">10.1016/S0165-1781(14)70004-6</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">25539874</PMID>        <DateCompleted>            <Year>2015</Year>            <Month>02</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2014</Year>            <Month>12</Month>            <Day>25</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1872-7123</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>220 Suppl 1</Volume>                    <PubDate>                        <Year>2014</Year>                        <Month>Dec</Month>                    </PubDate>                </JournalIssue>                <Title>Psychiatry research</Title>                <ISOAbbreviation>Psychiatry Res</ISOAbbreviation>            </Journal>            <ArticleTitle>Optimizing the management of depression: primary care experience.</ArticleTitle>            <Pagination>                <MedlinePgn>S45-57</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S0165-1781(14)70005-8</ELocationID>            <ELocationID EIdType="pii" ValidYN="Y">S0165-1781(14)70005-8</ELocationID>            <Abstract>                <AbstractText>This article is intended to identify some of the most important challenges faced by family physicians when treating MDD and to provide practical solutions. Key issues, reviewed from a primary care view point will include: treating to remission (and not just response), identification of high-risk groups, diagnosis, acute treatment approaches (including pharmacotherapy and the management of related side effects), the use of psychotherapy and somatic therapies, assessment of the adequacy of treatment including the assessment of remission, response measurement, optimal follow-up care throughout the phase of treatment, the key components of patient education and strategies for partial/limited response to the first-line antidepressant (switching, augmentation and combination strategies), how to provide support for improved treatment adherence, and approaches to prevent the recurrence of depressive episodes. </AbstractText>                <CopyrightInformation>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Cameron</LastName>                    <ForeName>Catherine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>START Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada; Northern Ontario School of Medicine, Thunder Bay, ON, Canada. Electronic address: ccameron@startclinic.ca.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Habert</LastName>                    <ForeName>Jeff</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Anand</LastName>                    <ForeName>Leena</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>START Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Furtado</LastName>                    <ForeName>Melissa</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>START Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Ireland</Country>            <MedlineTA>Psychiatry Res</MedlineTA>            <NlmUniqueID>7911385</NlmUniqueID>            <ISSNLinking>0165-1781</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019468" MajorTopicYN="Y">Disease Management</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Adherence</Keyword>            <Keyword MajorTopicYN="N">Antidepressants</Keyword>            <Keyword MajorTopicYN="N">Depressive disorders</Keyword>            <Keyword MajorTopicYN="N">MDD</Keyword>            <Keyword MajorTopicYN="N">Pharmacotherapy</Keyword>            <Keyword MajorTopicYN="N">Remission</Keyword>            <Keyword MajorTopicYN="N">Treatment</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2013</Year>                <Month>10</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2014</Year>                <Month>10</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2014</Year>                <Month>12</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2014</Year>                <Month>12</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2015</Year>                <Month>2</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">25539874</ArticleId>            <ArticleId IdType="pii">S0165-1781(14)70005-8</ArticleId>            <ArticleId IdType="doi">10.1016/S0165-1781(14)70005-8</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">25754289</PMID>        <DateCompleted>            <Year>2016</Year>            <Month>08</Month>            <Day>09</Day>        </DateCompleted>        <DateRevised>            <Year>2015</Year>            <Month>10</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1873-7811</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>41</Volume>                    <PubDate>                        <Year>2015</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Clinical psychology review</Title>                <ISOAbbreviation>Clin Psychol Rev</ISOAbbreviation>            </Journal>            <ArticleTitle>A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence.</ArticleTitle>            <Pagination>                <MedlinePgn>16-26</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cpr.2015.02.003</ELocationID>            <ELocationID EIdType="pii" ValidYN="Y">S0272-7358(15)00022-7</ELocationID>            <Abstract>                <AbstractText>Major depressive disorder (MDD) is highly disabling and typically runs a recurrent course. Knowledge about prevention of relapse and recurrence is crucial to the long-term welfare of people who suffer from this disorder. This article provides an overview of the current evidence for the prevention of relapse and recurrence using psychological interventions. We first describe a conceptual framework to preventive interventions based on: acute treatment; continuation treatment, or; prevention strategies for patients in remission. In brief, cognitive-behavioral interventions, delivered during the acute phase, appear to have an enduring effect that protects patients against relapse and perhaps others from recurrence following treatment termination. Similarly, continuation treatment with either cognitive therapy or perhaps interpersonal psychotherapy appears to reduce risk for relapse and maintenance treatment appears to reduce risk for recurrence. Preventive relapse strategies like preventive cognitive therapy or mindfulness based cognitive therapy (MBCT) applied to patients in remission protects against subsequent relapse and perhaps recurrence. There is some preliminary evidence of specific mediation via changing the content or the process of cognition. Continuation CT and preventive interventions started after remission (CBT, MBCT) seem to have the largest differential effects for individuals that need them the most. Those who have the greatest risk for relapse and recurrence including patients with unstable remission, more previous episodes, potentially childhood trauma, early age of onset. These prescriptive indications, if confirmed in future research, may point the way to personalizing prevention strategies. Doing so, may maximize the efficiency with which they are applied and have the potential to target the mechanisms that appear to underlie these effects. This may help make this prevention strategies more efficacious. </AbstractText>                <CopyrightInformation>Copyright © 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Bockting</LastName>                    <ForeName>Claudi L</ForeName>                    <Initials>CL</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Psychology, University of Groningen, Groningen, The Netherlands; Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands. Electronic address: c.l.h.bockting@uu.nl.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hollon</LastName>                    <ForeName>Steven D</ForeName>                    <Initials>SD</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology, Vanderbilt University, Nashville, TN, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jarrett</LastName>                    <ForeName>Robin B</ForeName>                    <Initials>RB</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kuyken</LastName>                    <ForeName>Willem</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, University of Oxford, Oxford OX1 2JD, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dobson</LastName>                    <ForeName>Keith</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology, University of Calgary, Alberta, Canada.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2015</Year>                <Month>02</Month>                <Day>26</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Clin Psychol Rev</MedlineTA>            <NlmUniqueID>8111117</NlmUniqueID>            <ISSNLinking>0272-7358</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Therapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment (Health Care)</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055502" MajorTopicYN="N">Secondary Prevention</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Depression</Keyword>            <Keyword MajorTopicYN="N">Prevention</Keyword>            <Keyword MajorTopicYN="N">Psychological intervention</Keyword>            <Keyword MajorTopicYN="N">Recurrence</Keyword>            <Keyword MajorTopicYN="N">Relapse</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2014</Year>                <Month>05</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2014</Year>                <Month>12</Month>                <Day>14</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2015</Year>                <Month>02</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2015</Year>                <Month>3</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2015</Year>                <Month>3</Month>                <Day>11</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2016</Year>                <Month>8</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">25754289</ArticleId>            <ArticleId IdType="pii">S0272-7358(15)00022-7</ArticleId>            <ArticleId IdType="doi">10.1016/j.cpr.2015.02.003</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">26854424</PMID>        <DateCompleted>            <Year>2017</Year>            <Month>01</Month>            <Day>19</Day>        </DateCompleted>        <DateRevised>            <Year>2017</Year>            <Month>03</Month>            <Day>01</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1878-5832</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>21</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2016</Year>                        <Month>Mar</Month>                    </PubDate>                </JournalIssue>                <Title>Drug discovery today</Title>                <ISOAbbreviation>Drug Discov. Today</ISOAbbreviation>            </Journal>            <ArticleTitle>Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.</ArticleTitle>            <Pagination>                <MedlinePgn>454-64</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drudis.2016.01.016</ELocationID>            <ELocationID EIdType="pii" ValidYN="Y">S1359-6446(16)30024-1</ELocationID>            <Abstract>                <AbstractText>Major depression is a chronic and debilitating illness that effects approximately 1 in 5 people, but currently available treatments are limited by low rates of efficacy, therapeutic time lag, and undesirable side effects. Recent efforts have been directed towards investigating rapid-acting agents that reverse the behavioral and neuronal deficits of chronic stress and depression, notably the glutamate NMDA receptor antagonist ketamine. The cellular mechanisms underlying the rapid antidepressant actions of ketamine and related agents are discussed, as well as novel, selective glutamatergic receptor targets that are safer and have fewer side effects. </AbstractText>                <CopyrightInformation>Copyright © 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Gerhard</LastName>                    <ForeName>Danielle M</ForeName>                    <Initials>DM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology, Yale University, New Haven, CT 06511, United States.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wohleb</LastName>                    <ForeName>Eric S</ForeName>                    <Initials>ES</Initials>                    <AffiliationInfo>                        <Affiliation>Molecular Psychiatry, Yale University, New Haven, CT 06711, United States.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Duman</LastName>                    <ForeName>Ronald S</ForeName>                    <Initials>RS</Initials>                    <AffiliationInfo>                        <Affiliation>Molecular Psychiatry, Yale University, New Haven, CT 06711, United States. Electronic address: ronald.duman@yale.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>R01 MH093897</GrantID>                    <Acronym>MH</Acronym>                    <Agency>NIMH NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01 MH105910</GrantID>                    <Acronym>MH</Acronym>                    <Agency>NIMH NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2016</Year>                <Month>02</Month>                <Day>06</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Drug Discov Today</MedlineTA>            <NlmUniqueID>9604391</NlmUniqueID>            <ISSNLinking>1359-6446</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018683">Excitatory Amino Acid Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D058785">GABA-A Receptor Agonists</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018727">Muscarinic Antagonists</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C121001">NR2B NMDA receptor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018094">Receptors, Metabotropic Glutamate</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016194">Receptors, N-Methyl-D-Aspartate</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>3KX376GY7L</RegistryNumber>                <NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>451IFR0GXB</RegistryNumber>                <NameOfSubstance UI="D012601">Scopolamine Hydrobromide</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>690G0D6V8H</RegistryNumber>                <NameOfSubstance UI="D007649">Ketamine</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2006 Jan;163(1):28-40</RefSource>                <PMID Version="1">16390886</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cereb Cortex. 1993 May-Jun;3(3):223-38</RefSource>                <PMID Version="1">7686795</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2011 Jul 7;475(7354):91-5</RefSource>                <PMID Version="1">21677641</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Neuropsychopharmacol. 2015 Jan;18(1). pii: pyu033. doi: 10.1093/ijnp/pyu033</RefSource>                <PMID Version="1">25539510</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2010 Jan 15;67(2):139-45</RefSource>                <PMID Version="1">19897179</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2010 Nov;35(12):2479-88</RefSource>                <PMID Version="1">20736989</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neurosci Biobehav Rev. 2009 May;33(5):699-771</RefSource>                <PMID Version="1">19428491</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychoneuroendocrinology. 2011 Nov;36(10):1562-9</RefSource>                <PMID Version="1">21596481</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neurosci. 1997 Apr 15;17(8):2921-7</RefSource>                <PMID Version="1">9092613</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2013 Apr;38(5):729-42</RefSource>                <PMID Version="1">23303054</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychopharmacol. 2008 Dec;28(6):631-7</RefSource>                <PMID Version="1">19011431</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Affect Disord. 2006 Jul;93(1-3):239-43</RefSource>                <PMID Version="1">16677714</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Neuropsychopharmacol. 2010 Jan;20(1):1-17</RefSource>                <PMID Version="1">19748235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2003 Jan 24;112(2):257-69</RefSource>                <PMID Version="1">12553913</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Brain Res. 2009 Oct 13;1293:108-13</RefSource>                <PMID Version="1">19361488</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2004 Mar;46(4):457-67</RefSource>                <PMID Version="1">14975669</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Geriatr Psychiatry. 2012 Jun;27(6):651-6</RefSource>                <PMID Version="1">22513699</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Rev. 2010 Sep;62(3):405-96</RefSource>                <PMID Version="1">20716669</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2005 May 15;57(10):1079-88</RefSource>                <PMID Version="1">15866546</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Psychiatry. 1981 Summer;20(3):636-44</RefSource>                <PMID Version="1">7031113</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Affect Disord. 2014 Jun;162:39-42</RefSource>                <PMID Version="1">24767003</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Drug Discov Today. 2010 May;15(9-10):371-83</RefSource>                <PMID Version="1">20206287</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Biochem Behav. 2006 Dec;85(4):842-9</RefSource>                <PMID Version="1">17204313</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2014 Dec 15;76(12):970-6</RefSource>                <PMID Version="1">24821196</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 2005 Jun;62(6):617-27</RefSource>                <PMID Version="1">15939839</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Dialogues Clin Neurosci. 2014 Mar;16(1):11-27</RefSource>                <PMID Version="1">24733968</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuroscience. 2010 Sep 15;169(4):1610-20</RefSource>                <PMID Version="1">20600670</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8649-54</RefSource>                <PMID Version="1">24912158</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 1991 Jul 15;30(2):157-69</RefSource>                <PMID Version="1">1655072</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Trends Neurosci. 2012 Jan;35(1):47-56</RefSource>                <PMID Version="1">22217452</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mol Psychiatry. 2013 Sep 17;1(1):15</RefSource>                <PMID Version="1">25408908</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pharmacol Exp Ther. 1999 Jan;288(1):204-10</RefSource>                <PMID Version="1">9862772</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>MMWR Surveill Summ. 2012 Sep 14;61(6):1-43</RefSource>                <PMID Version="1">22971797</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2015 May 12;112(19):6188-93</RefSource>                <PMID Version="1">25918363</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Psychiatry. 2014 Sep;19(9):978-85</RefSource>                <PMID Version="1">24126931</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2014 May;20(5):531-5</RefSource>                <PMID Version="1">24728411</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2013 Mar;66:40-52</RefSource>                <PMID Version="1">22640631</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neurosci. 2006 Jul 26;26(30):7870-4</RefSource>                <PMID Version="1">16870732</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neurosci. 2011 Mar 23;31(12):4475-83</RefSource>                <PMID Version="1">21430148</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuron. 1994 Mar;12(3):529-40</RefSource>                <PMID Version="1">7512349</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2012 Jan;62(1):3-12</RefSource>                <PMID Version="1">21807003</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pharmacol Exp Ther. 2014 Nov;351(2):448-56</RefSource>                <PMID Version="1">25187432</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2010 Nov;35(12):2378-91</RefSource>                <PMID Version="1">20686454</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2001 Apr;62(4):256-60</RefSource>                <PMID Version="1">11379839</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2008 Dec;55(7):1238-50</RefSource>                <PMID Version="1">18796308</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2006 Jan;163(1):153-5</RefSource>                <PMID Version="1">16390905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2010 Jan 22;140(2):174-6</RefSource>                <PMID Version="1">20141829</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Brain Struct Funct. 2008 Sep;213(1-2):93-118</RefSource>                <PMID Version="1">18704495</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2010 Aug 20;329(5994):959-64</RefSource>                <PMID Version="1">20724638</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2000 Feb 15;47(4):351-4</RefSource>                <PMID Version="1">10686270</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Trends Neurosci. 2010 Feb;33(2):67-75</RefSource>                <PMID Version="1">19963289</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Neuropsychopharmacol. 2013 Apr;16(3):501-6</RefSource>                <PMID Version="1">23174090</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Addiction. 2000 Apr;95(4):575-90</RefSource>                <PMID Version="1">10829333</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychopharmacol. 2012 Aug;32(4):551-7</RefSource>                <PMID Version="1">22722512</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 1959 May;115(11):1025-6</RefSource>                <PMID Version="1">13637281</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2007 Jul;32(7):1504-19</RefSource>                <PMID Version="1">17164818</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2002 Apr 10;287(14):1840-7</RefSource>                <PMID Version="1">11939870</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2006 May 1;59(9):812-5</RefSource>                <PMID Version="1">16442082</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuroscience. 2003;117(3):697-706</RefSource>                <PMID Version="1">12617973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2014 Jul;82:59-68</RefSource>                <PMID Version="1">24631968</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2012 Apr;37(5):1297-304</RefSource>                <PMID Version="1">22218094</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):359-64</RefSource>                <PMID Version="1">18172209</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2013 Nov;74:4-17</RefSource>                <PMID Version="1">23376022</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2011 Apr 15;69(8):754-61</RefSource>                <PMID Version="1">21292242</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2015 Feb;76(2):155-62</RefSource>                <PMID Version="1">25742202</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Emerg Med. 1999 Jul;17(4):387-93</RefSource>                <PMID Version="1">10452441</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2005 Aug;49(2):220-9</RefSource>                <PMID Version="1">15996568</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Neuroanat. 2013 Jul 17;7:23</RefSource>                <PMID Version="1">23882190</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Behav Brain Res. 2011 Oct 10;224(1):107-11</RefSource>                <PMID Version="1">21669235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Biochem Behav. 2002 Mar;71(3):431-47</RefSource>                <PMID Version="1">11830178</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Indian J Psychol Med. 2010 Jan;32(1):1-2</RefSource>                <PMID Version="1">21799550</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2012 Jun 1;71(11):1022-5</RefSource>                <PMID Version="1">22169441</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CMAJ. 2003 May 27;168(11):1439-42</RefSource>                <PMID Version="1">12771076</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2013 Nov 15;74(10):742-9</RefSource>                <PMID Version="1">23751205</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2006 Oct 6;314(5796):140-3</RefSource>                <PMID Version="1">17023662</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2015 Oct;40(11):2499-509</RefSource>                <PMID Version="1">25900119</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Neuropsychopharmacol. 2012 May;15(4):429-34</RefSource>                <PMID Version="1">22114864</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Psychiatr Pract. 2015 Mar;21(2):140-9</RefSource>                <PMID Version="1">25782764</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):102-6</RefSource>                <PMID Version="1">22651960</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2006 Feb 1;59(3):216-23</RefSource>                <PMID Version="1">16248986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2012 Sep;18(9):1413-7</RefSource>                <PMID Version="1">22885997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 1995 Jan 15;37(2):85-98</RefSource>                <PMID Version="1">7718684</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2010 Mar 1;67(5):432-8</RefSource>                <PMID Version="1">20074703</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):471-81</RefSource>                <PMID Version="1">9276848</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2000 Oct;157(10):1552-62</RefSource>                <PMID Version="1">11007705</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neurobiol Aging. 2011 Apr;32(4):698-706</RefSource>                <PMID Version="1">19446371</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2013 Aug 15;74(4):257-64</RefSource>                <PMID Version="1">23206319</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2012 Mar;37(4):851-64</RefSource>                <PMID Version="1">22169941</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2010 Feb 12;327(5967):863-6</RefSource>                <PMID Version="1">20075215</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pharmacol Exp Ther. 2015 Oct;355(1):76-85</RefSource>                <PMID Version="1">26265321</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neurochem. 2010 Dec;115(6):1608-20</RefSource>                <PMID Version="1">20969570</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ther Adv Chronic Dis. 2015 May;6(3):97-114</RefSource>                <PMID Version="1">25954495</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropharmacology. 2006 Nov;51(6):1023-9</RefSource>                <PMID Version="1">17046030</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2015 Feb 1;77(3):285-94</RefSource>                <PMID Version="1">25109665</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2012 Oct 5;338(6103):68-72</RefSource>                <PMID Version="1">23042884</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neurosci. 2012 Feb 15;32(7):2410-21</RefSource>                <PMID Version="1">22396415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neuropsychopharmacology. 2009 Jul;34(8):2028-40</RefSource>                <PMID Version="1">19242405</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Neurobiol Dis. 2015 Oct;82:254-61</RefSource>                <PMID Version="1">26102021</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2012 Jun 1;71(11):996-1005</RefSource>                <PMID Version="1">22036038</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 2006 Oct;63(10):1121-9</RefSource>                <PMID Version="1">17015814</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018683" MajorTopicYN="N">Excitatory Amino Acid Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D058785" MajorTopicYN="N">GABA-A Receptor Agonists</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018727" MajorTopicYN="N">Muscarinic Antagonists</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018094" MajorTopicYN="N">Receptors, Metabotropic Glutamate</DescriptorName>                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016194" MajorTopicYN="N">Receptors, N-Methyl-D-Aspartate</DescriptorName>                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012601" MajorTopicYN="N">Scopolamine Hydrobromide</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2015</Year>                <Month>08</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2016</Year>                <Month>01</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2016</Year>                <Month>01</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pmc-release">                <Year>2017</Year>                <Month>03</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2016</Year>                <Month>2</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2016</Year>                <Month>2</Month>                <Day>9</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2017</Year>                <Month>1</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">26854424</ArticleId>            <ArticleId IdType="pii">S1359-6446(16)30024-1</ArticleId>            <ArticleId IdType="doi">10.1016/j.drudis.2016.01.016</ArticleId>            <ArticleId IdType="pmc">PMC4803609</ArticleId>            <ArticleId IdType="mid">NIHMS758223</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">26879925</PMID>        <DateCompleted>            <Year>2016</Year>            <Month>09</Month>            <Day>28</Day>        </DateCompleted>        <DateRevised>            <Year>2017</Year>            <Month>11</Month>            <Day>07</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1535-1645</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>18</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2016</Year>                        <Month>Mar</Month>                    </PubDate>                </JournalIssue>                <Title>Current psychiatry reports</Title>                <ISOAbbreviation>Curr Psychiatry Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>Depression During Pregnancy and Postpartum.</ArticleTitle>            <Pagination>                <MedlinePgn>32</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11920-016-0664-7</ELocationID>            <Abstract>                <AbstractText>Depression is a common complication of pregnancy and the postpartum period. There are multiple risk factors for peripartum mood disorders, most important of which is a prior history of depression. Both depression and antidepressant medications confer risk upon the infant. Maternal depression has been associated with preterm birth, low birth weight, fetal growth restriction, and postnatal cognitive and emotional complications. Antidepressant exposure has been associated with preterm birth, reductions in birth weight, persistent pulmonary hypertension, and postnatal adaptation syndrome (PNAS) as well as a possible connection with autism spectrum disorder. Paroxetine has been associated with cardiac malformations. Most antidepressant medications are excreted in low levels in breast milk and are generally compatible with breastfeeding. The use of antidepressants during pregnancy and postpartum must be weighed against the risk of untreated depression in the mother. </AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Becker</LastName>                    <ForeName>Madeleine</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry and Human Behavior, Thomas Jefferson University Hospital, 1020 Sansom Street, Thompson Bldg, Suite 1652, Philadelphia, PA, 19107, USA. Madeleine.Becker@jefferson.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weinberger</LastName>                    <ForeName>Tal</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry and Human Behavior, Thomas Jefferson University Hospital, 833 Chestnut St. 2nd floor, Suite 210, Philadelphia, PA, 19107, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chandy</LastName>                    <ForeName>Ann</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry and Human Behavior, Thomas Jefferson University Hospital, 1020 Sansom Street, Thompson Bldg, Suite 1652, Philadelphia, PA, 19107, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schmukler</LastName>                    <ForeName>Sarah</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry and Human Behavior, Thomas Jefferson University Hospital, 1020 Sansom Street, Thompson Bldg, Suite 1652, Philadelphia, PA, 19107, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Curr Psychiatry Rep</MedlineTA>            <NlmUniqueID>100888960</NlmUniqueID>            <ISSNLinking>1523-3812</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):246-52</RefSource>                <PMID Version="1">19148882</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2015 Apr 17;350:h1798</RefSource>                <PMID Version="1">25888213</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Can Fam Physician. 2013 Jun;59(6):633-4</RefSource>                <PMID Version="1">23766044</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Affect Disord. 2015 Jan 15;171:142-54</RefSource>                <PMID Version="1">25305429</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breastfeed Med. 2011 Apr;6(2):89-98</RefSource>                <PMID Version="1">20958101</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2001 Jul;158(7):1001-9</RefSource>                <PMID Version="1">11431219</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2001 Jan;158(1):49-57</RefSource>                <PMID Version="1">11136633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Psychopharmacol. 2015 Jan;30(1):4-20</RefSource>                <PMID Version="1">25572308</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Perinatol. 2007 Feb;27(2):120-2</RefSource>                <PMID Version="1">17262045</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2007 Jun 28;356(26):2675-83</RefSource>                <PMID Version="1">17596601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Hum Lact. 2005 Nov;21(4):444-9; quiz 450-4</RefSource>                <PMID Version="1">16280561</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychopharmacol. 2015 Jun;35(3):250-9</RefSource>                <PMID Version="1">25830592</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2004 Jun;65(6):881-2</RefSource>                <PMID Version="1">15291673</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Annu Rev Clin Psychol. 2014;10:369-92</RefSource>                <PMID Version="1">24313569</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacotherapy. 2014;34(4):389-95</RefSource>                <PMID Version="1">24390829</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Psychiatr Scand. 2013 Feb;127(2):94-114</RefSource>                <PMID Version="1">23240634</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Obstet Gynecol. 2008 Apr;111(4):1001-20</RefSource>                <PMID Version="1">18378767</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Child Adolesc Psychiatry. 2014 Oct;23(10):973-92</RefSource>                <PMID Version="1">24863148</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2007 Jun 28;356(26):2732-3</RefSource>                <PMID Version="1">17596609</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Aug 31;10(8):e0135471</RefSource>                <PMID Version="1">26322643</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2007 Feb;164(2):348-9</RefSource>                <PMID Version="1">17267804</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatrics. 2014 May;133(5):e1241-8</RefSource>                <PMID Version="1">24733881</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Clin Pharmacol. 1999 Oct;48(4):521-7</RefSource>                <PMID Version="1">10583022</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2014 Dec;75(12):e1423-7</RefSource>                <PMID Version="1">25551238</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2006 Feb 9;354(6):579-87</RefSource>                <PMID Version="1">16467545</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Drug Saf. 2007;30(2):107-21</RefSource>                <PMID Version="1">17253877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Epidemiol. 2013 Nov 15;5:449-59</RefSource>                <PMID Version="1">24255601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2004 Dec;161(12):2325</RefSource>                <PMID Version="1">15569912</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Mar 26;9(3):e92778</RefSource>                <PMID Version="1">24671232</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Womens Ment Health. 2015 Feb;18(1):113-21</RefSource>                <PMID Version="1">24980575</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Psychiatry. 2013 Apr;70(4):436-43</RefSource>                <PMID Version="1">23446732</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychopharmacol. 2014 Apr;34(2):226-9</RefSource>                <PMID Version="1">24525643</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Can J Psychiatry. 2003 Mar;48(2):106-10</RefSource>                <PMID Version="1">12655908</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Hum Lact. 2010 May;26(2):187-95</RefSource>                <PMID Version="1">19652194</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1075-85</RefSource>                <PMID Version="1">17729379</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Epigenetics. 2008 Mar-Apr;3(2):97-106</RefSource>                <PMID Version="1">18536531</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2009 May;166(5):557-66</RefSource>                <PMID Version="1">19289451</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Obstet Gynecol. 2009 Sep;52(3):483-97</RefSource>                <PMID Version="1">19661763</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 2011 Nov;68(11):1104-12</RefSource>                <PMID Version="1">21727247</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Lab Clin Med. 2002 Apr;139(4):194-201</RefSource>                <PMID Version="1">12024106</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Womens Ment Health. 2011 Feb;14(1):49-53</RefSource>                <PMID Version="1">20960017</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CNS Spectr. 2004 Mar;9(3):198-206</RefSource>                <PMID Version="1">14999160</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ Open. 2014 Nov 14;4(11):e004883</RefSource>                <PMID Version="1">25398675</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Womens Ment Health. 2015 Feb;18(1):41-60</RefSource>                <PMID Version="1">25422150</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Womens Ment Health. 2003 Nov;6(4):263-74</RefSource>                <PMID Version="1">14628179</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Psychiatry. 2013 May;70(5):490-8</RefSource>                <PMID Version="1">23487258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2010 Jul 28;304(4):419-25</RefSource>                <PMID Version="1">20664042</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2002 Oct;63(10):910-1</RefSource>                <PMID Version="1">12416600</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Obstet Gynecol. 2005 Mar;192(3):932-6</RefSource>                <PMID Version="1">15746694</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Affect Disord. 2005 Sep;88(1):9-18</RefSource>                <PMID Version="1">15979150</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatrics. 2006 Aug;118(2):659-68</RefSource>                <PMID Version="1">16882821</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Ther. 2009 Jun;31 Pt 1:1426-53</RefSource>                <PMID Version="1">19698902</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2004 Jun;161(6):1066-78</RefSource>                <PMID Version="1">15169695</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Obstet Gynecol. 2010 Jul;203(1):52.e1-6</RefSource>                <PMID Version="1">20417496</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Psychiatry. 2008 May;192(5):338-43</RefSource>                <PMID Version="1">18450656</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Obstet Gynecol. 2015 May;125(5):1268-71</RefSource>                <PMID Version="1">25932866</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94</RefSource>                <PMID Version="1">17729378</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2005 May 18;293(19):2372-83</RefSource>                <PMID Version="1">15900008</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Womens Ment Health. 2012 Feb;15(1):1-14</RefSource>                <PMID Version="1">22215285</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychopharmacol. 2009 Apr;29(2):191-2</RefSource>                <PMID Version="1">19512989</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2007 Jun 28;356(26):2684-92</RefSource>                <PMID Version="1">17596602</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Clin Pharmacol. 2007 Mar;63(3):322-7</RefSource>                <PMID Version="1">16970569</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2014 Oct;75(10):e1142-52</RefSource>                <PMID Version="1">25373125</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2013 Apr;74(4):e293-308</RefSource>                <PMID Version="1">23656855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2008 Jun;165(6):749-52</RefSource>                <PMID Version="1">18381907</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 1993 Nov;32(6):1253-5</RefSource>                <PMID Version="1">8282672</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 1996 Oct 3;335(14):1010-5</RefSource>                <PMID Version="1">8793924</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2014 Nov 15;384(9956):1775-88</RefSource>                <PMID Version="1">25455248</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2014 Jan 14;348:f6932</RefSource>                <PMID Version="1">24429387</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Birth Defects Res A Clin Mol Teratol. 2007 Apr;79(4):301-8</RefSource>                <PMID Version="1">17216624</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):13-8</RefSource>                <PMID Version="1">24094568</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2006 Feb 1;295(5):499-507</RefSource>                <PMID Version="1">16449615</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CNS Drugs. 2006;20(3):187-98</RefSource>                <PMID Version="1">16529525</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2013 Apr 19;346:f2059</RefSource>                <PMID Version="1">23604083</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):159-70</RefSource>                <PMID Version="1">19739149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2006 Aug;67(8):1280-4</RefSource>                <PMID Version="1">16965209</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Psychol Rev. 2013 Dec;33(8):1205-17</RefSource>                <PMID Version="1">24211712</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2012 Jan 12;344:d8012</RefSource>                <PMID Version="1">22240235</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 2010 Oct;67(10):1012-24</RefSource>                <PMID Version="1">20921117</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Pediatr (Phila). 2003 May;42(4):325-40</RefSource>                <PMID Version="1">12800727</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Infant Behav Dev. 2008 Sep;31(3):481-7</RefSource>                <PMID Version="1">18272227</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Drug Metab Toxicol. 2015;11(10):1585-97</RefSource>                <PMID Version="1">26135630</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):801-6</RefSource>                <PMID Version="1">18314924</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):94-100</RefSource>                <PMID Version="1">19937603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychiatry Res. 2014 Feb 28;215(2):341-6</RefSource>                <PMID Version="1">24370337</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):823-7</RefSource>                <PMID Version="1">15742359</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2007 Aug;164(8):1206-13</RefSource>                <PMID Version="1">17671283</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2014 Dec 13;384(9960):2084</RefSource>                <PMID Version="1">25497185</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Womens Health Rev. 2011 Feb;7(1):28-34</RefSource>                <PMID Version="1">22299006</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2013 Apr;74(4):e321-41</RefSource>                <PMID Version="1">23656857</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):919-27</RefSource>                <PMID Version="1">19625979</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Popul Ther Clin Pharmacol. 2014;21(3):e533-41</RefSource>                <PMID Version="1">25594738</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Affect Disord. 2009 Dec;119(1-3):116-23</RefSource>                <PMID Version="1">19342104</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gen Hosp Psychiatry. 2004 Jul-Aug;26(4):289-95</RefSource>                <PMID Version="1">15234824</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nurs Res. 2001 Sep-Oct;50(5):275-85</RefSource>                <PMID Version="1">11570712</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pediatr Adolesc Med. 2006 Mar;160(3):279-84</RefSource>                <PMID Version="1">16520447</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Psychiatr Pract. 2009 May;15(3):183-92</RefSource>                <PMID Version="1">19461391</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Infant Behav Dev. 2012 Dec;35(4):613-26</RefSource>                <PMID Version="1">22982260</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Pregnancy Childbirth. 2015 Aug 25;15:192</RefSource>                <PMID Version="1">26303856</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2014 Jun 19;370(25):2397-407</RefSource>                <PMID Version="1">24941178</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Nurs. 2015 Jan;18(1):15-6</RefSource>                <PMID Version="1">24858440</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Womens Ment Health. 2015 Apr;18(2):187-95</RefSource>                <PMID Version="1">25088531</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Med. 2010 Oct;40(10):1723-33</RefSource>                <PMID Version="1">20047705</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychopharmacol. 2007 Dec;27(6):607-13</RefSource>                <PMID Version="1">18004128</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Clin Pharmacol. 1986 Sep;22(3):367-70</RefSource>                <PMID Version="1">3768252</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fed Regist. 2014 Dec 4;79(233):72063-103</RefSource>                <PMID Version="1">25509060</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2006 Jan;67(1):126-36</RefSource>                <PMID Version="1">16426099</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2015 Jun 2;313(21):2142-51</RefSource>                <PMID Version="1">26034955</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tob Control. 2004 Mar;13(1):52-6</RefSource>                <PMID Version="1">14985597</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gen Hosp Psychiatry. 2009 Sep-Oct;31(5):403-13</RefSource>                <PMID Version="1">19703633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Womens Ment Health. 2005 Jun;8(2):77-87</RefSource>                <PMID Version="1">15883651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Matern Fetal Neonatal Med. 2014 Jun;27(9):960-7</RefSource>                <PMID Version="1">24044422</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001942" MajorTopicYN="N">Breast Feeding</DescriptorName>                <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019052" MajorTopicYN="N">Depression, Postpartum</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D049590" MajorTopicYN="N">Postpartum Period</DescriptorName>                <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Antidepressants</Keyword>            <Keyword MajorTopicYN="N">Depression</Keyword>            <Keyword MajorTopicYN="N">Lactation</Keyword>            <Keyword MajorTopicYN="N">Postpartum depression</Keyword>            <Keyword MajorTopicYN="N">Pregnancy</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2016</Year>                <Month>2</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2016</Year>                <Month>2</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2016</Year>                <Month>9</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">26879925</ArticleId>            <ArticleId IdType="doi">10.1007/s11920-016-0664-7</ArticleId>            <ArticleId IdType="pii">10.1007/s11920-016-0664-7</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">26559241</PMID>        <DateCompleted>            <Year>2016</Year>            <Month>03</Month>            <Day>03</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>05</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1756-1833</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>351</Volume>                    <PubDate>                        <Year>2015</Year>                        <Month>Nov</Month>                        <Day>11</Day>                    </PubDate>                </JournalIssue>                <Title>BMJ (Clinical research ed.)</Title>                <ISOAbbreviation>BMJ</ISOAbbreviation>            </Journal>            <ArticleTitle>Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial.</ArticleTitle>            <Pagination>                <MedlinePgn>h5627</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.h5627</ELocationID>            <Abstract>                <AbstractText Label="STUDY QUESTION" NlmCategory="OBJECTIVE">How effective is supported computerised cognitive behaviour therapy (cCBT) as an adjunct to usual primary care for adults with depression?</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This was a pragmatic, multicentre, three arm, parallel randomised controlled trial with simple randomisation. Treatment allocation was not blinded. Participants were adults with symptoms of depression (score ≥ 10 on nine item patient health questionnaire, PHQ-9) who were randomised to receive a commercially produced cCBT programme (&quot;Beating the Blues&quot;) or a free to use cCBT programme (MoodGYM) in addition to usual GP care. Participants were supported and encouraged to complete the programme via weekly telephone calls. Control participants were offered usual GP care, with no constraints on the range of treatments that could be accessed. The primary outcome was severity of depression assessed with the PHQ-9 at four months. Secondary outcomes included health related quality of life (measured by SF-36) and psychological wellbeing (measured by CORE-OM) at four, 12, and 24 months and depression at 12 and 24 months.</AbstractText>                <AbstractText Label="STUDY ANSWER AND LIMITATIONS" NlmCategory="UNASSIGNED">Participants offered commercial or free to use cCBT experienced no additional improvement in depression compared with usual GP care at four months (odds ratio 1.19 (95% confidence interval 0.75 to 1.88) for Beating the Blues v usual GP care; 0.98 (0.62 to 1.56) for MoodGYM v usual GP care). There was no evidence of an overall difference between either programme compared with usual GP care (0.99 (0.57 to 1.70) and 0.68 (0.42 to 1.10), respectively) at any time point. Commercially provided cCBT conferred no additional benefit over free to use cCBT or usual GP care at any follow-up point. Uptake and use of cCBT was low, despite regular telephone support. Nearly a quarter of participants (24%) had dropped out by four months. The study did not have enough power to detect small differences so these cannot be ruled out. Findings cannot be generalised to cCBT offered with a much higher level of guidance and support.</AbstractText>                <AbstractText Label="WHAT THIS STUDY ADDS" NlmCategory="CONCLUSIONS">Supported cCBT does not substantially improve depression outcomes compared with usual GP care alone. In this study, neither a commercially available nor free to use computerised CBT intervention was superior to usual GP care.</AbstractText>                <AbstractText Label="FUNDING, COMPETING INTERESTS, DATA SHARING" NlmCategory="UNASSIGNED">Commissioned and funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project No 06/43/05). The authors have no competing interests. Requests for patient level data will be considered by the REEACT trial management groupTrial registration Current Controlled Trials ISRCTN91947481.</AbstractText>                <CopyrightInformation>© Gilbody et al 2015.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Gilbody</LastName>                    <ForeName>Simon</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Health Sciences, University of York, York YO10 5DD, UK simon.gilbody@york.ac.uk.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Littlewood</LastName>                    <ForeName>Elizabeth</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Health Sciences, University of York, York YO10 5DD, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hewitt</LastName>                    <ForeName>Catherine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>York Trials Unit, Department of Health Sciences, University of York, York YO10 5DD, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brierley</LastName>                    <ForeName>Gwen</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tharmanathan</LastName>                    <ForeName>Puvan</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>York Trials Unit, Department of Health Sciences, University of York, York YO10 5DD, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Araya</LastName>                    <ForeName>Ricardo</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Barkham</LastName>                    <ForeName>Michael</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Centre for Psychological Services Research, Department of Psychology, University of Sheffield, Sheffield S10 2TP, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bower</LastName>                    <ForeName>Peter</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>NIHR School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9NT, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cooper</LastName>                    <ForeName>Cindy</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield S1 4DA, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gask</LastName>                    <ForeName>Linda</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>NIHR School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9NT, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kessler</LastName>                    <ForeName>David</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol BS8 2BN, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lester</LastName>                    <ForeName>Helen</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Primary Care Clinical Sciences Building, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lovell</LastName>                    <ForeName>Karina</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>School of Nursing, Midwifery and Social Work, University of Manchester, Manchester M13 9PL, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Parry</LastName>                    <ForeName>Glenys</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>School of Health and Related Research, University of Sheffield, Sheffield S1 4DA, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Richards</LastName>                    <ForeName>David A</ForeName>                    <Initials>DA</Initials>                    <AffiliationInfo>                        <Affiliation>University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Andersen</LastName>                    <ForeName>Phil</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Health Sciences, University of York, York YO10 5DD, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brabyn</LastName>                    <ForeName>Sally</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Health Sciences, University of York, York YO10 5DD, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Knowles</LastName>                    <ForeName>Sarah</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>NIHR School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9NT, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shepherd</LastName>                    <ForeName>Charles</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Faculty of Health and Social Care, University of Hull, Hull HU6 7RX, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tallon</LastName>                    <ForeName>Debbie</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol BS8 2BN, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>White</LastName>                    <ForeName>David</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield S1 4DA, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>REEACT Team</CollectiveName>                </Author>            </AuthorList>            <Language>eng</Language>            <DataBankList CompleteYN="Y">                <DataBank>                    <DataBankName>ISRCTN</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>ISRCTN91947481</AccessionNumber>                    </AccessionNumberList>                </DataBank>            </DataBankList>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>HTA/06/43/504</GrantID>                    <Agency>Department of Health</Agency>                    <Country>United Kingdom</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D003160">Comparative Study</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016448">Multicenter Study</PublicationType>                <PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType>                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2015</Year>                <Month>11</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMJ</MedlineTA>            <NlmUniqueID>8900488</NlmUniqueID>            <ISSNLinking>0959-8138</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>BMJ. 2015;351:h5942</RefSource>                <PMID Version="1">26561033</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="ErratumIn">                <RefSource>BMJ. 2016;352:i195</RefSource>                <PMID Version="1">26759375</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Gen Pract. 2009 Feb;59(559):e51-60</RefSource>                <PMID Version="1">19192368</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2004 Jan 31;328(7434):265</RefSource>                <PMID Version="1">14742346</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Technol Assess. 2006 Sep;10(33):iii, xi-xiv, 1-168</RefSource>                <PMID Version="1">16959169</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2002 May 18;324(7347):1183</RefSource>                <PMID Version="1">12016181</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2006 Apr 29;332(7548):1030-2</RefSource>                <PMID Version="1">16644834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 1999 Nov 10;282(18):1737-44</RefSource>                <PMID Version="1">10568646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CMAJ. 2012 Feb 21;184(3):E191-6</RefSource>                <PMID Version="1">22184363</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Technol Assess. 2015 Dec;19(101):1-174</RefSource>                <PMID Version="1">26685904</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2009 Aug 22;374(9690):628-34</RefSource>                <PMID Version="1">19700005</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Consult Clin Psychol. 2001 Apr;69(2):184-96</RefSource>                <PMID Version="1">11393596</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Technol Assess. 2000;4(19):1-83</RefSource>                <PMID Version="1">11086269</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ Open. 2015;5(11):e008581</RefSource>                <PMID Version="1">26621513</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Psychiatry. 2004 May;184:386-92</RefSource>                <PMID Version="1">15123501</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cogn Behav Ther. 2009;38(4):196-205</RefSource>                <PMID Version="1">20183695</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Med. 2007 Mar;37(3):319-28</RefSource>                <PMID Version="1">17112400</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Policy. 1990 Dec;16(3):199-208</RefSource>                <PMID Version="1">10109801</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Med. 1992 May;22(2):465-86</RefSource>                <PMID Version="1">1615114</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Technol Assess. 2005 May;9(16):1-134, iii</RefSource>                <PMID Version="1">15876362</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Psychiatry. 2005 Jan;186:11-7</RefSource>                <PMID Version="1">15630118</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2009;338:b750</RefSource>                <PMID Version="1">19299475</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Med. 2009 May;39(5):705-12</RefSource>                <PMID Version="1">18812006</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Med. 2008 Nov;38(11):1521-30</RefSource>                <PMID Version="1">18205964</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2010;5(10):e13196</RefSource>                <PMID Version="1">20967242</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Med. 2003 Feb;33(2):217-27</RefSource>                <PMID Version="1">12622301</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2004 Sep;161(9):1692-7</RefSource>                <PMID Version="1">15337661</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Postgrad Med J. 2008 Oct;84(996):545-8</RefSource>                <PMID Version="1">19017840</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2011;6(6):e21274</RefSource>                <PMID Version="1">21712998</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Rev Psychiatry. 2011 Aug;23(4):318-27</RefSource>                <PMID Version="1">22026487</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World Psychiatry. 2014 Oct;13(3):288-95</RefSource>                <PMID Version="1">25273302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med. 2010;8:18</RefSource>                <PMID Version="1">20334633</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Psychiatry. 2013;13:113</RefSource>                <PMID Version="1">23587347</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Therapy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D037001" MajorTopicYN="N">Directive Counseling</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>                <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013689" MajorTopicYN="N">Telephone</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013813" MajorTopicYN="N">Therapy, Computer-Assisted</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2015</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2015</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2016</Year>                <Month>3</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">26559241</ArticleId>            <ArticleId IdType="pmc">PMC4641883</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">25200567</PMID>        <DateCompleted>            <Year>2014</Year>            <Month>12</Month>            <Day>14</Day>        </DateCompleted>        <DateRevised>            <Year>2017</Year>            <Month>11</Month>            <Day>13</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1179-2019</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>16</Volume>                    <Issue>5</Issue>                    <PubDate>                        <Year>2014</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Paediatric drugs</Title>                <ISOAbbreviation>Paediatr Drugs</ISOAbbreviation>            </Journal>            <ArticleTitle>Management of treatment-resistant depression in children and adolescents.</ArticleTitle>            <Pagination>                <MedlinePgn>353-61</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40272-014-0088-y</ELocationID>            <Abstract>                <AbstractText>Depression is a relatively common diagnosis in children and adolescents, and is associated with significant morbidity and suicidality in this population. Evidence-based treatment of the acute illness is imperative to try to prevent the development of treatment-resistant depression or other complications. In situations where response to acute treatment is inadequate, clinicians should first consider factors that may influence outcome, such as psychiatric or medical comorbidities, psychosocial stressors, and treatment noncompliance. Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for depression in children and adolescents. For treatment-resistant depression, a switch to an alternate SSRI is recommended before trials of other antidepressants. Psychotherapy, such as cognitive behavioral therapy or interpersonal therapy, may improve treatment response. More research is needed examining medication augmentation strategies for treatment-resistant depression in children and adolescents. </AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>DeFilippis</LastName>                    <ForeName>Melissa</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Child and Adolescent Psychiatry, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555-0188, USA, msdefili@utmb.edu.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wagner</LastName>                    <ForeName>Karen Dineen</ForeName>                    <Initials>KD</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Paediatr Drugs</MedlineTA>            <NlmUniqueID>100883685</NlmUniqueID>            <ISSNLinking>1174-5878</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2010 Jul;167(7):782-91</RefSource>                <PMID Version="1">20478877</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 1997 Sep;54(9):877-85</RefSource>                <PMID Version="1">9294380</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):59-75</RefSource>                <PMID Version="1">16553529</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tijdschr Psychiatr. 2008;50(1):23-31</RefSource>                <PMID Version="1">18188826</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int Clin Psychopharmacol. 2009 Nov;24(6):277-88</RefSource>                <PMID Version="1">19738481</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851</RefSource>                <PMID Version="1">23152227</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatrics. 2014 Feb;133(2):204-10</RefSource>                <PMID Version="1">24394688</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 1999 Jun;56(6):573-9</RefSource>                <PMID Version="1">10359475</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2008 Feb 27;299(8):901-13</RefSource>                <PMID Version="1">18314433</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2014 Jan;75(1):15-21</RefSource>                <PMID Version="1">24345304</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1412-8</RefSource>                <PMID Version="1">17135986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Child Adolesc Psychopharmacol. 2001 Spring;11(1):69-75</RefSource>                <PMID Version="1">11322748</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2004 Aug 18;292(7):807-20</RefSource>                <PMID Version="1">15315995</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Child Psychol Psychiatry. 1996 Sep;37(6):737-46</RefSource>                <PMID Version="1">8894955</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Affect Disord. 2013 Oct;151(1):298-305</RefSource>                <PMID Version="1">23829999</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Consult Clin Psychol. 1999 Oct;67(5):734-45</RefSource>                <PMID Version="1">10535240</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 1999 Mar;38(3):272-9</RefSource>                <PMID Version="1">10087688</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J ECT. 2012 Jun;28(2):84-6</RefSource>                <PMID Version="1">22531199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Child Psychol Psychiatry. 2005 Jul;46(7):735-54</RefSource>                <PMID Version="1">15972068</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Child Adolesc Psychopharmacol. 2005 Aug;15(4):696-702</RefSource>                <PMID Version="1">16190801</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Depress Anxiety. 2011 Nov;28(11):946-54</RefSource>                <PMID Version="1">21898710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Psychiatry. 2010 Dec;197(6):433-40</RefSource>                <PMID Version="1">21119148</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychopharmacol. 2006 Jun;26(3):311-5</RefSource>                <PMID Version="1">16702897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2014 Apr;171(4):404-15</RefSource>                <PMID Version="1">24362450</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):721-9</RefSource>                <PMID Version="1">19465881</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1503-26</RefSource>                <PMID Version="1">18049300</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J ECT. 2011 Jun;27(2):168-74</RefSource>                <PMID Version="1">21233763</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Depress Anxiety. 2010 May;27(5):426-33</RefSource>                <PMID Version="1">20112246</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1427-39</RefSource>                <PMID Version="1">17135988</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2008 Apr;165(4):459-67</RefSource>                <PMID Version="1">18281410</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychol Bull. 2006 Jan;132(1):132-49</RefSource>                <PMID Version="1">16435960</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Affect Disord. 2012 Apr;138(1-2):173-9</RefSource>                <PMID Version="1">22310035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pediatr. 2006 Feb;148(2):158-65</RefSource>                <PMID Version="1">16492422</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bone. 2012 Sep;51(3):606-13</RefSource>                <PMID Version="1">22659406</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2003 Aug 27;290(8):1033-41</RefSource>                <PMID Version="1">12941675</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 2007 Oct;64(10):1132-43</RefSource>                <PMID Version="1">17909125</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CNS Neurosci Ther. 2010 Apr;16(2):83-90</RefSource>                <PMID Version="1">19769598</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pediatr Ann. 2011 Jun;40(6):300-6</RefSource>                <PMID Version="1">21678888</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2012 Apr 18;344:e2598</RefSource>                <PMID Version="1">22517917</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Intern Med. 2014 Jun;174(6):899-909</RefSource>                <PMID Version="1">24782035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2006 Jun;163(6):1098-100</RefSource>                <PMID Version="1">16741212</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J ECT. 2008 Jun;24(2):156-9</RefSource>                <PMID Version="1">18580562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 1997 Nov;54(11):1031-7</RefSource>                <PMID Version="1">9366660</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychiatry Clin Neurosci. 2009 Aug;63(4):463-70</RefSource>                <PMID Version="1">19531111</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):709-19</RefSource>                <PMID Version="1">16721321</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324</RefSource>                <PMID Version="1">23152255</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2013 Jun;170(6):642-50</RefSource>                <PMID Version="1">23640689</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 2011 Mar;68(3):263-9</RefSource>                <PMID Version="1">21041606</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2007 Apr 18;297(15):1683-96</RefSource>                <PMID Version="1">17440145</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2004 Jun;161(6):1079-83</RefSource>                <PMID Version="1">15169696</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 1996 Sep;35(9):1120-9</RefSource>                <PMID Version="1">8824055</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72</RefSource>                <PMID Version="1">11437014</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2007 Jun;46(6):667-86</RefSource>                <PMID Version="1">17513980</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2009 Feb;48(2):186-95</RefSource>                <PMID Version="1">19127172</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Diabetes Care. 1996 Apr;19(4):318-23</RefSource>                <PMID Version="1">8729153</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Technol Assess. 2008 May;12(14):iii-iv, ix-60</RefSource>                <PMID Version="1">18462573</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9</RefSource>                <PMID Version="1">20855043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1205-15</RefSource>                <PMID Version="1">12364842</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2006 Mar;45(3):280-8</RefSource>                <PMID Version="1">16540812</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CNS Spectr. 2007 Mar;12(3):223-33</RefSource>                <PMID Version="1">17329983</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Gen Psychiatry. 2004 Jun;61(6):577-84</RefSource>                <PMID Version="1">15184237</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2004 Dec;43(12):1521-39</RefSource>                <PMID Version="1">15564821</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cochrane Database Syst Rev. 2012 Nov 14;11:CD007504</RefSource>                <PMID Version="1">23152246</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2014 May;75(5):e441-9</RefSource>                <PMID Version="1">24922496</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):307-14</RefSource>                <PMID Version="1">11288772</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2010 Feb;49(2):122-31</RefSource>                <PMID Version="1">20215934</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Acad Child Adolesc Psychiatry. 2008 Dec;47(12):1395-404</RefSource>                <PMID Version="1">18978634</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017367" MajorTopicYN="N">Serotonin Uptake Inhibitors</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2014</Year>                <Month>9</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2014</Year>                <Month>9</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2014</Year>                <Month>12</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">25200567</ArticleId>            <ArticleId IdType="doi">10.1007/s40272-014-0088-y</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">27488181</PMID>        <DateCompleted>            <Year>2017</Year>            <Month>11</Month>            <Day>27</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>01</Month>            <Day>03</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1745-6215</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>17</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2016</Year>                        <Month>08</Month>                        <Day>03</Day>                    </PubDate>                </JournalIssue>                <Title>Trials</Title>                <ISOAbbreviation>Trials</ISOAbbreviation>            </Journal>            <ArticleTitle>European COMPARative Effectiveness research on blended Depression treatment versus treatment-as-usual (E-COMPARED): study protocol for a randomized controlled, non-inferiority trial in eight European countries.</ArticleTitle>            <Pagination>                <MedlinePgn>387</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-016-1511-1</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND">Effective, accessible, and affordable depression treatment is of high importance considering the large personal and economic burden of depression. Internet-based treatment is considered a promising clinical and cost-effective alternative to current routine depression treatment strategies such as face-to-face psychotherapy. However, it is not clear whether research findings translate to routine clinical practice such as primary or specialized mental health care. The E-COMPARED project aims to gain knowledge on the clinical and cost-effectiveness of blended depression treatment compared to treatment-as-usual in routine care.</AbstractText>                <AbstractText Label="METHODS/DESIGN">E-COMPARED will employ a pragmatic, multinational, randomized controlled, non-inferiority trial in eight European countries. Adults diagnosed with major depressive disorder (MDD) will be recruited in primary care (Germany, Poland, Spain, Sweden, and the United Kingdom) or specialized mental health care (France, The Netherlands, and Switzerland). Regular care for depression is compared to &quot;blended&quot; service delivery combining mobile and Internet technologies with face-to-face treatment in one treatment protocol. Participants will be followed up at 3, 6, and 12 months after baseline to determine clinical improvements in symptoms of depression (primary outcome: Patient Health Questionnaire-9), remission of depression, and cost-effectiveness. Main analyses will be conducted on the pooled data from the eight countries (n = 1200 in total, 150 participants in each country).</AbstractText>                <AbstractText Label="DISCUSSION">The E-COMPARED project will provide mental health care stakeholders with evidence-based information and recommendations on the clinical and cost-effectiveness of blended depression treatment.</AbstractText>                <AbstractText Label="TRIAL REGISTRATION">France: ClinicalTrials.gov NCT02542891 . Registered on 4 September 2015; Germany: German Clinical Trials Register DRKS00006866 . Registered on 2 December 2014; The Netherlands: Netherlands Trials Register NTR4962 . Registered on 5 January 2015; Poland: ClinicalTrials.Gov NCT02389660 . Registered on 18 February 2015; Spain: ClinicalTrials.gov NCT02361684 . Registered on 8 January 2015; Sweden: ClinicalTrials.gov NCT02449447 . Registered on 30 March 2015; Switzerland: ClinicalTrials.gov NCT02410616 . Registered on 2 April 2015; United Kingdom: ISRCTN registry, ISRCTN12388725 . Registered on 20 March 2015.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kleiboer</LastName>                    <ForeName>Annet</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Section Clinical Psychology, Vrije Universiteit Amsterdam and EMGO+ Institute for Health Care and Research, Van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands. a.m.kleiboer@vu.nl.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Smit</LastName>                    <ForeName>Jan</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, VU University Medical Centre and EMGO+ Institute for Health Care and Research, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bosmans</LastName>                    <ForeName>Judith</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Health Sciences, Vrije Universiteit Amsterdam and EMGO+ Institute for Health and Care Research, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ruwaard</LastName>                    <ForeName>Jeroen</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Section Clinical Psychology, Vrije Universiteit Amsterdam and EMGO+ Institute for Health Care and Research, Van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Andersson</LastName>                    <ForeName>Gerhard</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Behavioural Sciences and Learning, Swedish Institute for Disability Research, Linköping University, Linköping, Sweden.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Topooco</LastName>                    <ForeName>Naira</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Behavioural Sciences and Learning, Swedish Institute for Disability Research, Linköping University, Linköping, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Berger</LastName>                    <ForeName>Thomas</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Psychology and Psychotherapy, University of Bern, Bern, Switzerland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Krieger</LastName>                    <ForeName>Tobias</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Psychology and Psychotherapy, University of Bern, Bern, Switzerland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Botella</LastName>                    <ForeName>Cristina</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology and Technology, Jaume University, Castellon, Spain.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Personalidad, Evaluación y Tratamiento Psicológicos, Valencia, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Baños</LastName>                    <ForeName>Rosa</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Personalidad, Evaluación y Tratamiento Psicológicos, Valencia, Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chevreul</LastName>                    <ForeName>Karine</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>URC-ECO, Ile-de-France (AP-HP), Paris, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Araya</LastName>                    <ForeName>Ricardo</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cerga-Pashoja</LastName>                    <ForeName>Arlinda</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cieślak</LastName>                    <ForeName>Roman</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology, Szkoła Wyzsza Psychologii Społeczne, University of Social Sciences and Humanities, Warsaw, Poland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rogala</LastName>                    <ForeName>Anna</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychology, Szkoła Wyzsza Psychologii Społeczne, University of Social Sciences and Humanities, Warsaw, Poland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vis</LastName>                    <ForeName>Christiaan</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Section Clinical Psychology, Vrije Universiteit Amsterdam and EMGO+ Institute for Health Care and Research, Van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Draisma</LastName>                    <ForeName>Stasja</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, VU University Medical Centre and EMGO+ Institute for Health Care and Research, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>van Schaik</LastName>                    <ForeName>Anneke</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, VU University Medical Centre and EMGO+ Institute for Health Care and Research, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kemmeren</LastName>                    <ForeName>Lise</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, VU University Medical Centre and EMGO+ Institute for Health Care and Research, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ebert</LastName>                    <ForeName>David</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Psychology, Philipps University, Marburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Berking</LastName>                    <ForeName>Matthias</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Psychology, Philipps University, Marburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Funk</LastName>                    <ForeName>Burkhardt</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Institut für elektronische Geschäftsprozesse, Leuphana University Lüneburg, Lüneburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cuijpers</LastName>                    <ForeName>Pim</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Section Clinical Psychology, Vrije Universiteit Amsterdam and EMGO+ Institute for Health Care and Research, Van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Riper</LastName>                    <ForeName>Heleen</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Section Clinical Psychology, Vrije Universiteit Amsterdam and EMGO+ Institute for Health Care and Research, Van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, VU University Medical Centre and EMGO+ Institute for Health Care and Research, Amsterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <DataBankList CompleteYN="Y">                <DataBank>                    <DataBankName>ClinicalTrials.gov</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>NCT02389660</AccessionNumber>                        <AccessionNumber>NCT02449447</AccessionNumber>                        <AccessionNumber>NCT02542891</AccessionNumber>                        <AccessionNumber>NCT02410616</AccessionNumber>                        <AccessionNumber>NCT02361684</AccessionNumber>                    </AccessionNumberList>                </DataBank>                <DataBank>                    <DataBankName>DRKS</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>DRKS00006866</AccessionNumber>                    </AccessionNumberList>                </DataBank>                <DataBank>                    <DataBankName>ISRCTN</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>ISRCTN12388725</AccessionNumber>                    </AccessionNumberList>                </DataBank>                <DataBank>                    <DataBankName>NTR</DataBankName>                    <AccessionNumberList>                        <AccessionNumber>NTR4962</AccessionNumber>                    </AccessionNumberList>                </DataBank>            </DataBankList>            <PublicationTypeList>                <PublicationType UI="D000073843">Equivalence Trial</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016448">Multicenter Study</PublicationType>                <PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType>                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2016</Year>                <Month>08</Month>                <Day>03</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Trials</MedlineTA>            <NlmUniqueID>101263253</NlmUniqueID>            <ISSNLinking>1745-6215</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2013 Jan 08;346:e7586</RefSource>                <PMID Version="1">23303884</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gen Intern Med. 2001 Sep;16(9):606-13</RefSource>                <PMID Version="1">11556941</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Psychol Rev. 2011 Nov;31(7):1117-25</RefSource>                <PMID Version="1">21820991</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Psychiatry. 2014 Apr;171(4):453-62</RefSource>                <PMID Version="1">24434956</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Rev Neurother. 2016;16(1):55-60</RefSource>                <PMID Version="1">26610160</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Decis Making. 1990 Jul-Sep;10(3):212-4</RefSource>                <PMID Version="1">2115096</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Soc Sci Med. 1994 Dec;39(11):1537-44</RefSource>                <PMID Version="1">7817218</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Psychol Rev. 2010 Feb;30(1):51-62</RefSource>                <PMID Version="1">19781837</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Care. 2004 Dec;42(12):1194-201</RefSource>                <PMID Version="1">15550799</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Psychiatry. 2014 Oct 08;14:285</RefSource>                <PMID Version="1">25298158</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Ment Health Policy Econ. 2006 Dec;9(4):193-200</RefSource>                <PMID Version="1">17200596</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eval Program Plann. 1983;6(3-4):299-313</RefSource>                <PMID Version="1">10267258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Econ. 2004 May;13(5):405-15</RefSource>                <PMID Version="1">15127421</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57</RefSource>                <PMID Version="1">9881538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Depress Anxiety. 2009;26(3):279-88</RefSource>                <PMID Version="1">19031487</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Depress Anxiety. 2014 May;31(5):374-8</RefSource>                <PMID Version="1">24677535</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Can J Psychiatry. 2013 Jul;58(7):376-85</RefSource>                <PMID Version="1">23870719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79</RefSource>                <PMID Version="1">21924589</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Psychol Rev. 2012 Jun;32(4):329-42</RefSource>                <PMID Version="1">22466510</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Psychiatry. 2015 Nov;2(11):1036-42</RefSource>                <PMID Version="1">26404415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Psychiatry. 2013 Feb 20;13:64</RefSource>                <PMID Version="1">23425435</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Mar 12;9(3):e91053</RefSource>                <PMID Version="1">24622046</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Policy. 1990 Dec;16(3):199-208</RefSource>                <PMID Version="1">10109801</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2010 Mar 23;340:c332</RefSource>                <PMID Version="1">20332509</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Ment Health Policy Econ. 2006 Jun;9(2):87-98</RefSource>                <PMID Version="1">17007486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gen Hosp Psychiatry. 2007 Sep-Oct;29(5):388-95</RefSource>                <PMID Version="1">17888804</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86</RefSource>                <PMID Version="1">11132119</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Psychiatr Scand. 2001 Jul;104(1):19-24</RefSource>                <PMID Version="1">11437745</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Psychiatry. 2003 Sep 1;54(5):573-83</RefSource>                <PMID Version="1">12946886</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Psychiatry. 2014 Oct 18;14:290</RefSource>                <PMID Version="1">25326035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2013 Nov 27;310(20):2191-4</RefSource>                <PMID Version="1">24141714</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Econ. 2004 May;13(5):461-75</RefSource>                <PMID Version="1">15127426</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Psychiatry. 2001 Nov;179:417-25</RefSource>                <PMID Version="1">11689399</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JMIR Ment Health. 2016 Feb 09;3(1):e9</RefSource>                <PMID Version="1">26860537</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Psychiatry. 2013 Jan 11;13:21</RefSource>                <PMID Version="1">23312003</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gen Intern Med. 2007 Nov;22(11):1596-602</RefSource>                <PMID Version="1">17874169</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychiatry. 2008 Nov;69(11):1675-85; quiz 1839-41</RefSource>                <PMID Version="1">18945396</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Trials. 2011 May 03;12:106</RefSource>                <PMID Version="1">21539749</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health Expect. 2009 Mar;12(1):45-59</RefSource>                <PMID Version="1">19250152</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Psychiatry. 2014 Dec 14;14:355</RefSource>                <PMID Version="1">25496393</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Neurol. 2012 Jan;19(1):155-62</RefSource>                <PMID Version="1">22175760</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Perspect Psychol Sci. 2011 Jan;6(1):21-37</RefSource>                <PMID Version="1">26162113</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D002985" MajorTopicYN="N">Clinical Protocols</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015928" MajorTopicYN="Y">Cognitive Therapy</DescriptorName>                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D057186" MajorTopicYN="Y">Comparative Effectiveness Research</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003865" MajorTopicYN="N">Depressive Disorder, Major</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>                <QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013813" MajorTopicYN="Y">Therapy, Computer-Assisted</DescriptorName>                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">Adults</Keyword>            <Keyword MajorTopicYN="Y">Blended treatment</Keyword>            <Keyword MajorTopicYN="Y">Cognitive behavioral treatment (CBT)</Keyword>            <Keyword MajorTopicYN="Y">Comparative effectiveness research (CER)</Keyword>            <Keyword MajorTopicYN="Y">Cost-effectiveness</Keyword>            <Keyword MajorTopicYN="Y">Depression</Keyword>            <Keyword MajorTopicYN="Y">Internet-based treatment</Keyword>            <Keyword MajorTopicYN="Y">Randomized controlled trial (RCT)</Keyword>            <Keyword MajorTopicYN="Y">eHealth</Keyword>            <Keyword MajorTopicYN="Y">iCBT</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2016</Year>                <Month>04</Month>                <Day>13</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2016</Year>                <Month>06</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2016</Year>                <Month>8</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2016</Year>                <Month>8</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2017</Year>                <Month>11</Month>                <Day>29</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">27488181</ArticleId>            <ArticleId IdType="doi">10.1186/s13063-016-1511-1</ArticleId>            <ArticleId IdType="pii">10.1186/s13063-016-1511-1</ArticleId>            <ArticleId IdType="pmc">PMC4972947</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">27571438</PMID>        <DateCompleted>            <Year>2017</Year>            <Month>05</Month>            <Day>01</Day>        </DateCompleted>        <DateRevised>            <Year>2017</Year>            <Month>05</Month>            <Day>01</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">2168-6114</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>176</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2016</Year>                        <Month>Oct</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>JAMA internal medicine</Title>                <ISOAbbreviation>JAMA Intern Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Treatment of Adult Depression in the United States.</ArticleTitle>            <Pagination>                <MedlinePgn>1482-1491</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2016.5057</ELocationID>            <Abstract>                <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Despite recent increased use of antidepressants in the United States, concerns persist that many adults with depression do not receive treatment, whereas others receive treatments that do not match their level of illness severity.</AbstractText>                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To characterize the treatment of adult depression in the United States.</AbstractText>                <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">Analysis of screen-positive depression, psychological distress, and depression treatment data from 46 417 responses to the Medical Expenditure Panel Surveys taken in US households by participants aged 18 years or older in 2012 and 2013.</AbstractText>                <AbstractText Label="Main Outcome and Measures" NlmCategory="UNASSIGNED">Percentages of adults with screen-positive depression (Patient Health Questionnaire-2 score of ≥ 3) and adjusted odds ratios (AORs) of the effects of sociodemographic characteristics on odds of screen-positive depression; percentages with treatment for screen-positive depression and AORs; percentages with any treatment of depression and AORs stratified by presence of serious psychological distress (Kessler 6 scale score of ≥13); and percentages with depression treatment by health care professional group (psychiatrists, other health care professionals, and general medical providers); and type of depression treatment (antidepressants, psychotherapy, and both) all stratified by distress level.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Approximately 8.4% (95% CI, 7.9-8.8) of adults screened positive for depression, of which 28.7% received any depression treatment. Conversely, among all adults treated for depression, 29.9% had screen-positive depression and 21.8% had serious psychological distress. Adults with serious compared with less serious psychological distress who were treated for depression were more likely to receive care from psychiatrists (33.4% vs 17.3%, P &lt; .001) or other mental health specialists (16.2% vs 9.6%, P &lt; .001), and less likely to receive depression care exclusively from general medical professionals (59.0% vs 74.4%, P &lt; .001). They were also more likely to receive psychotherapy (32.5% vs 20.6%, P &lt; .001), though not antidepressant medications (81.1% vs 88.6%, P &lt; .001).</AbstractText>                <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">Most US adults who screen positive for depression did not receive treatment for depression, whereas most who were treated did not screen positive. In light of these findings, it is important to strengthen efforts to align depression care with each patient's clinical needs.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Olfson</LastName>                    <ForeName>Mark</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Psychiatry, College of Physicians and Surgeons, Columbia University and New York State Psychiatric Institute, New York.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Blanco</LastName>                    <ForeName>Carlos</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>National Institute on Drug Abuse, Bethesda, Maryland.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Marcus</LastName>                    <ForeName>Steven C</ForeName>                    <Initials>SC</Initials>                    <AffiliationInfo>                        <Affiliation>School of Social Practice &amp; Policy, University of Pennsylvania, Philadelphia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>JAMA Intern Med</MedlineTA>            <NlmUniqueID>101589534</NlmUniqueID>            <ISSNLinking>2168-6106</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014151">Anti-Anxiety Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="ErratumIn">                <RefSource>JAMA Intern Med. 2016 Oct 1;176(10):1579</RefSource>                <PMID Version="1">27695830</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014151" MajorTopicYN="N">Anti-Anxiety Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004363" MajorTopicYN="N">Drug Utilization</DescriptorName>                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004522" MajorTopicYN="N">Educational Status</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D058005" MajorTopicYN="N">General Practitioners</DescriptorName>                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019458" MajorTopicYN="N">Insurance Coverage</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017533" MajorTopicYN="N">Marital Status</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017057" MajorTopicYN="N">Medically Uninsured</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011570" MajorTopicYN="N">Psychiatry</DescriptorName>                <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011613" MajorTopicYN="N">Psychotherapy</DescriptorName>                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2016</Year>                <Month>8</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2017</Year>                <Month>5</Month>                <Day>2</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2016</Year>                <Month>8</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">27571438</ArticleId>            <ArticleId IdType="pii">2546155</ArticleId>            <ArticleId IdType="doi">10.1001/jamainternmed.2016.5057</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">26813211</PMID>        <DateCompleted>            <Year>2016</Year>            <Month>02</Month>            <Day>04</Day>        </DateCompleted>        <DateRevised>            <Year>2016</Year>            <Month>10</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1538-3598</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>315</Volume>                    <Issue>4</Issue>                    <PubDate>                        <Year>2016</Year>                        <Month>Jan</Month>                        <Day>26</Day>                    </PubDate>                </JournalIssue>                <Title>JAMA</Title>                <ISOAbbreviation>JAMA</ISOAbbreviation>            </Journal>            <ArticleTitle>Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement.</ArticleTitle>            <Pagination>                <MedlinePgn>380-7</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2015.18392</ELocationID>            <Abstract>                <AbstractText Label="DESCRIPTION" NlmCategory="METHODS">Update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for depression in adults.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">The USPSTF reviewed the evidence on the benefits and harms of screening for depression in adult populations, including older adults and pregnant and postpartum women; the accuracy of depression screening instruments; and the benefits and harms of depression treatment in these populations.</AbstractText>                <AbstractText Label="POPULATION" NlmCategory="METHODS">This recommendation applies to adults 18 years and older.</AbstractText>                <AbstractText Label="RECOMMENDATION" NlmCategory="CONCLUSIONS">The USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation).</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Siu</LastName>                    <ForeName>Albert L</ForeName>                    <Initials>AL</Initials>                    <AffiliationInfo>                        <Affiliation>Mount Sinai School of Medicine, New York2James J. Peters Veterans Affairs Medical Center, Bronx, New York.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>US Preventive Services Task Force (USPSTF)</CollectiveName>                </Author>                <Author ValidYN="Y">                    <LastName>Bibbins-Domingo</LastName>                    <ForeName>Kirsten</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>University of California, San Francisco.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Grossman</LastName>                    <ForeName>David C</ForeName>                    <Initials>DC</Initials>                    <AffiliationInfo>                        <Affiliation>Group Health Research Institute, Seattle, Washington.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Baumann</LastName>                    <ForeName>Linda Ciofu</ForeName>                    <Initials>LC</Initials>                    <AffiliationInfo>                        <Affiliation>University of Wisconsin, Madison.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Davidson</LastName>                    <ForeName>Karina W</ForeName>                    <Initials>KW</Initials>                    <AffiliationInfo>                        <Affiliation>Columbia University, New York, New York.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ebell</LastName>                    <ForeName>Mark</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>University of Georgia, Athens.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>García</LastName>                    <ForeName>Francisco A R</ForeName>                    <Initials>FA</Initials>                    <AffiliationInfo>                        <Affiliation>Pima County Department of Health, Tucson, Arizona.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gillman</LastName>                    <ForeName>Matthew</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Herzstein</LastName>                    <ForeName>Jessica</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Independent consultant, Washington, DC.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kemper</LastName>                    <ForeName>Alex R</ForeName>                    <Initials>AR</Initials>                    <AffiliationInfo>                        <Affiliation>Duke University, Durham, North Carolina.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Krist</LastName>                    <ForeName>Alex H</ForeName>                    <Initials>AH</Initials>                    <AffiliationInfo>                        <Affiliation>Fairfax Family Practice, Fairfax, Virginia13Virginia Commonwealth University, Richmond.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kurth</LastName>                    <ForeName>Ann E</ForeName>                    <Initials>AE</Initials>                    <AffiliationInfo>                        <Affiliation>New York University, New York.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Owens</LastName>                    <ForeName>Douglas K</ForeName>                    <Initials>DK</Initials>                    <AffiliationInfo>                        <Affiliation>Veterans Affairs Palo Alto Health Care System, Palo Alto, California16Stanford University, Stanford, California.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Phillips</LastName>                    <ForeName>William R</ForeName>                    <Initials>WR</Initials>                    <AffiliationInfo>                        <Affiliation>University of Washington, Seattle.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Phipps</LastName>                    <ForeName>Maureen G</ForeName>                    <Initials>MG</Initials>                    <AffiliationInfo>                        <Affiliation>Brown University, Providence, Rhode Island.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pignone</LastName>                    <ForeName>Michael P</ForeName>                    <Initials>MP</Initials>                    <AffiliationInfo>                        <Affiliation>University of North Carolina, Chapel Hill.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D017065">Practice Guideline</PublicationType>                <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>JAMA</MedlineTA>            <NlmUniqueID>7501160</NlmUniqueID>            <ISSNLinking>0098-7484</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D018687">Antidepressive Agents, Second-Generation</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="CommentIn">                <RefSource>BMJ. 2016;353:i2174</RefSource>                <PMID Version="1">27090432</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D026683" MajorTopicYN="Y">Advisory Committees</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018687" MajorTopicYN="N">Antidepressive Agents, Second-Generation</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019052" MajorTopicYN="N">Depression, Postpartum</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2016</Year>                <Month>1</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2016</Year>                <Month>1</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2016</Year>                <Month>2</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">26813211</ArticleId>            <ArticleId IdType="pii">2484345</ArticleId>            <ArticleId IdType="doi">10.1001/jama.2015.18392</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>